(Q81318588)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17878922%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

editorial

0 references

title

Mouse models and the RANKL/OPG axis in myeloma bone disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17878922%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

1

Dingli D

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17878922%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Russell SJ

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17878922%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17878922%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17878922%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17878922%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17878922%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

2090-2093

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17878922%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404875

7 January 2020

exact match

0 references

cites work

A new xenograft model of myeloma bone disease demonstrating the efficacy of human mesenchymal stem cells expressing osteoprotegerin by lentiviral gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404875

7 January 2021

Imaging of myeloma bone disease--implications for staging, prognosis and follow-up

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404875

7 January 2021

Magnetic resonance and computed tomography imaging in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404875

7 January 2021

Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404875

7 January 2021

Multiple myeloma bone disease: Pathophysiology of osteoblast inhibition.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404875

7 January 2021

New potential targets for treating myeloma bone disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404875

7 January 2021

Phenotypic and molecular analysis of six human cell lines derived from patients with plasma cell dyscrasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404875

7 January 2021

Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404875

7 January 2021

Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404875

7 January 2021

Marked osteoblastopenia and reduced bone formation in a model of multiple myeloma bone disease in severe combined immunodeficiency mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404875

7 January 2021

Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404875

7 January 2021

Inhibition of bone-derived insulin-like growth factors by a ligand-specific antibody suppresses the growth of human multiple myeloma in the human adult bone explanted in NOD/SCID mouse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404875

7 January 2021

Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404875

7 January 2021

T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404875

7 January 2021

Dual effects of macrophage inflammatory protein-1alpha on osteolysis and tumor burden in the murine 5TGM1 model of myeloma bone disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404875

7 January 2021

Biology of osteoclast activation in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404875

7 January 2021

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404875

7 January 2021

Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404875

7 January 2021

Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404875

7 January 2021

Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404875

7 January 2021

Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404875

7 January 2021

A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404875

7 January 2021

Native osteoprotegerin gene transfer inhibits the development of murine osteolytic bone disease induced by tumor xenografts.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404875

7 January 2021

TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404875

7 January 2021

TRAIL-induced eradication of primary tumour cells from multiple myeloma patient bone marrows is not related to TRAIL receptor expression or prior chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404875

7 January 2021

An osteoprotegerin-like peptidomimetic inhibits osteoclastic bone resorption and osteolytic bone disease in myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404875

7 January 2021